Tag: Chemotherapy

Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates

Significant and clinically relevant improvement seen in objective response rate with encorafenib + cetuximab plus mFOLFOX6

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence

Improved survival seen with perioperative chemotherapy with FLOT versus preoperative chemoradiotherapy

Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury

Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage

Addition of camrelizumab improves pathological complete response in early or locally advanced triple negative breast cancer

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM

Estimated disease-free survival 97.5 ± 1.3 and 90.2 ± 2.3 percent with chemotherapy plus blinatumomab, chemo alone in average-risk patients

Findings seen in patients with microsatellite-instability-high or mismatch-repair-deficient metastatic colorectal cancer